CIVCO plans new RT platform launch at ESTRO
May 3, 2022 -- Radiation therapy (RT) products provider CIVCO Radiotherapy will be introducing its TotalRT platform at the European Society for Radiotherapy and Oncology (ESTRO) meeting in Denmark this week. Read More
Accuray sees Q3 revenues decreases, names new CEO
April 29, 2022 -- Accuray released financial results for the third quarter of the 2022 fiscal year showing a decline in revenue from the previous year. The company also announced promotions, including a new CEO. Read More
Qsam doses first patient in Cyclosam clinical trial
April 29, 2022 -- Qsam Biosciences said the first patient has begun treatment in the company's clinical trial evaluating samarium-153-DOTMP (CycloSam) for the treatment of bone cancer and related diseases. Read More
Midtherapy PET/CT predicts response in patients with esophageal cancer
April 22, 2022 -- Performing PET/CT scans while patients are undergoing radiotherapy prior to surgery for esophageal cancer can help predict whether they will respond to treatment, according to a study published April 18 in Radiotherapy and Oncology. Read More
ITM, MTTI ink lutetium-177 supply deal
April 13, 2022 -- ITM Isotope Technologies Munich's subsidiary ITM Medical Isotopes and biopharmaceutical company Molecular Targeting Technologies (MTTI) have signed a supply deal for no-carrier-added lutetium-177. Read More
NYSE accepts Navidea bid to comply with stock listing rules
April 13, 2022 -- Radiopharmaceutical developer Navidea Biopharmaceuticals said the New York Stock Exchange (NYSE) has accepted its plan to regain compliance with the stock exchange's listing requirements. Navidea now has until July 28, 2023, to regain compliance. Read More
FDA clears clinical trial for Blue Earth radiopharmaceutical
April 12, 2022 -- The U.S. Food and Drug Administration (FDA) has given the go-ahead to Blue Earth Therapeutics to conduct a clinical study of its radiopharmaceutical labeled with lutetium-177 for treatment of metastatic, castrate-resistant prostate cancer. Read More
Sun Nuclear releases SaaS option for SunCheck
April 11, 2022 -- Radiation oncology quality-assurance technology developer Sun Nuclear has released a cloud-hosted software-as-a-service (SaaS) option for its SunCheck radiation therapy quality assurance management platform. Read More
CMS again delays start of RO Model for radiation therapy payments
April 6, 2022 -- A major restructuring of the way the U.S. Centers for Medicare and Medicaid Services (CMS) pay for radiation therapy treatments, the Radiation Oncology Alternative Payment Model (RO Model), has been delayed again -- this time into the indefinite future. Read More
GE joins forces with Elekta in radiation oncology
April 5, 2022 -- GE Healthcare and radiation oncology firm Elekta have signed a global commercial collaboration agreement. Read More
Special Feature
Representation in radiation oncology remains challenging

Radiation oncology has some of the lowest numbers when it comes to female senior faculty representation, according to research published in JAMA Network Open. Read more